Anika is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with clinicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, and regenerative solutions.
Our Focus
Since our incorporation in 1992, Anika has evolved into a market leader in joint preservation. Our comprehensive portfolio of solutions for osteoarthritis pain management, and regenerative solutions, provides expansive treatment options for managing and addressing joint pain across the early intervention continuum of care. Our broad portfolio provides patient care options by managing pain, thus delaying or avoiding a more invasive procedure, and in some cases, slowing the progression of osteoarthritis. With solutions ranging from viscosupplement injections to treat osteoarthritis pain, and regenerative solutions that repair damaged tissues and tendons, our focus is to restore active living and help people stay active.
Anika’s culture is defined by its employees who are purpose-driven and passionate about our vision to be a global leader in joint preservation solutions that restore active living for people around the world.
Our Values
People
We engage with and invest in each other in a community that values diversity and inclusion.
Quality
We strive for the highest quality and compliance in everything
we do.
Integrity
We live up to our promises and do the right thing, every day.
Innovation
We are agile and entrepreneurial in developing and delivering meaningful solutions.
Teamwork
We operate with mutual respect and trust and are collaborative as we grow together.
Accountability
We are empowered and accountable to deliver results and value to all our stakeholders.
Our Products and Technology
Osteoarthritis (OA) Pain Management
With over 30 years of global expertise developing, manufacturing and commercializing products based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body and vital for proper joint health and tissue function, we are a leader in viscosupplement injectables for osteoarthritis (OA) pain management. Our key OA pain viscosupplement products include Orthovisc and Monovisc, which are exclusively marketed and sold in the US through the DePuy Synthes division of Johnson and Johnson and outside the US by Anika and our wide network of global commercial partners, and Cingal, an HA-based combination viscosupplement with steroid injectable, currently available in more than 35 countries outside the US through a wide network of global commercial partners.
Regenerative Solutions
Our portfolio of orthopedic regenerative solutions is driven by our proprietary HA technologies. These products include Hyalofast, an off-the-shelf, single stage, 100% hyaluronic acid scaffold for cartilage repair that supports hyaline-like cartilage regeneration, available in more than 35 countries outside the US, Integrity, an HA-based scaffold for rotator cuff repair and other tendon repair procedures that provides strength and supports tissue regeneration, and Tactoset, an HA-enhanced injectable, settable bone substitute that supports cell-mediated regeneration of new bone and is designed to treat insufficiency fractures and augment hardware fixation, such as suture anchors.
Sports Medicine
Anika expanded its commitment to the orthopedics space through the acquisition of Parcus Medical in 2020, a company offering a comprehensive range of solutions, including for the repair and reconstruction of soft tissues, commonly used in sports medicine procedures. Our team works diligently with physicians to develop and deliver innovative repair devices that offer healthcare providers compelling options to treat their patients and keep them active.